Adam H. Zaeske - 07 Apr 2026 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Reporting relationship: CHIEF COMMERCIAL OFFICER
Issuer ticker: HRMY
Reported as of: 07 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Apr 2026, 16:15:13 UTC
Prior SEC filing: 26 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Christian Ulrich, Attorney-in-Fact

Key filing fact

Adam H. Zaeske filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 09 Apr 2026.

Key facts

This page summarizes Adam H. Zaeske's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Apr 2026, 16:15.

Change

Previous filing in this sequence was filed on 26 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002064712 Primary reporting owner

Zaeske Adam H.

Relationship: CHIEF COMMERCIAL OFFICER
Address: C/O HARMONY BIOSCIENCES HOLDINGS, INC., PLYMOUTH MEETING
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Signature date: 09 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HRMY transaction

Common Stock

Options Exercise

Transaction value
Shares: +7,500
Change %
Price: $0.000000^*
Shares after: 7,500
Date: 07 Apr 2026
Ownership: Direct

HRMY transaction

Common Stock

Tax liability

Transaction value
Shares: -3,173
Change %: -42%
Price: $27.62^*
Shares after: 4,327
Date: 07 Apr 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRMY transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -7,500
Change %: -50%
Price: $0.000000^*
Shares after: 7,500
Date: 07 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date

Footnote F2

The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.